SCYNEXIS/ US8112922005 /
17/05/2024 21:59:12 | Var. +0.38 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
2.77USD | +15.69% | 6,238 Fatturato: 17,186.08 |
-Quantità in denaro: - | -Quantità in lettera: - | 2.89 | 2.50 |
GlobeNewswire
15:04
CC IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages The Chemours Company Investors to S...
GlobeNewswire
14:00
Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP a...
GlobeNewswire
14:00
ValueZone's CEO Pledges to Lead in Cutting-Edge Quantitative Trading for Enhanced Passive Income
GlobeNewswire
13:00
MERGER INVESTIGATION NOTICE: Investor Protection Law Firm Kaskela Law LLC Announces Shareholder Inve...